FDA warns of counterfeit versions of Adderall
The Food and Drug Administration (FDA) is warning consumers that counterfeit versions of Adderall, used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, have been sold through the Internet. Adderall is a controlled substance that is only available by prescription.
The counterfeit versions of the drug involve the 30 mg dosage. They were found to contain the wrong active ingredients. Adderall contains dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate. The counterfeit version of Adderall contains the painkillers tramadol and acetaminophen.
Adderall is currently on the FDA’s short supply list because its active ingredients are in short supply. This has opened the door for rogue websites to offer counterfeit versions of these short-supply drugs.
The counterfeit versions of Adderall are round and white with no markings of any type. Authentic Adderall 30 mg produced by Teva Pharmaceuticals are round, orange/peach, and scored with “dp” embossed on one side and “30” on the other side. Teva’s Adderall 30 mg tablets are packaged only in a 100-count bottle with the National Drug Code (NDC) 0555-0768-02 listed.
Anyone who believes they have the counterfeit version of Teva’s Adderall 30 mg tablets should not take or should stop taking the product. Consumers should talk to their health care professional about their condition and options for treatment.
Consumers and health care professionals are encouraged to report adverse events or side effects from the suspect counterfeit Adderall to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.